Our Pricing

Understanding Mounjaro: Clinical Evidence and UK Availability

Published on: June 03, 2026

If you're searching for mounjaro in stock uk price match options, Cured Pharmacy offers genuine UK-licensed Mounjaro (tirzepatide) pens with transparent upfront pricing and our lowest price guarantee. Our UK-registered clinical team provides free consultations, and we ensure continuous stock availability with discreet next-day delivery across the UK.

How Mounjaro Works for Weight Loss

Mounjaro contains tirzepatide, the first dual GIP/GLP-1 receptor agonist licensed by the MHRA for weight management in the UK [1]. Unlike single-pathway treatments, tirzepatide activates both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, which work together to regulate appetite, slow gastric emptying, and improve insulin sensitivity.

In the landmark SURPASS-3 trial, patients receiving the 15mg maintenance dose achieved an average body weight reduction of 22.5% over 72 weeks [1]. The SURMOUNT-1 trial demonstrated similar results in patients without diabetes, with participants losing an average of 20.9% body weight on the highest dose [2]. These outcomes represent significantly greater weight reduction compared to earlier single-pathway GLP-1 treatments.

The dual-agonist mechanism means Mounjaro addresses multiple metabolic pathways simultaneously. GLP-1 activation reduces appetite and food intake, whilst GIP activation enhances the metabolic response and may improve fat utilisation [3]. This combined approach explains why clinical trials have consistently shown superior weight loss outcomes with tirzepatide compared to semaglutide-based alternatives.

Mounjaro Dosing Schedule and What to Expect

Mounjaro follows a structured dose escalation schedule designed to minimise gastrointestinal side effects whilst optimising efficacy. Treatment begins with a 2.5mg once-weekly injection for the first four weeks, serving as an initial dose rather than a therapeutic maintenance level [4]. After this starter period, your prescriber will increase the dose to 5mg weekly, with further increases every four weeks as tolerated.

The standard maintenance doses range from 5mg to 15mg weekly, depending on individual response and tolerability. Most patients reach their optimal maintenance dose within 20-24 weeks of starting treatment. Clinical trials show that higher doses correlate with greater weight loss, but your UK prescriber will determine the appropriate dose based on your medical history, current medications, and how well you tolerate each escalation step.

During dose escalation, it's normal to experience mild nausea or reduced appetite as your body adjusts to each new strength. These effects typically diminish within a few days. Your prescriber may recommend staying at a particular dose longer if side effects are troublesome, or progressing more quickly if you're tolerating treatment well with minimal adverse effects.

Injection Technique and Storage

Mounjaro KwikPens are pre-filled single-dose injectors administered subcutaneously once weekly, on the same day each week. Injection sites include the abdomen, thigh, or upper arm, and you should rotate sites with each dose to reduce injection site reactions. The pen delivers the full dose automatically when pressed against the skin for 5-10 seconds.

Store unused pens in the refrigerator at 2-8°C until first use. Once removed from refrigeration, pens may be kept at room temperature (not exceeding 30°C) for up to 21 days. Never freeze Mounjaro, and always check the solution is clear and colourless before injecting. Our pharmacy team provides detailed administration instructions with every prescription.

Mounjaro In Stock UK Price Match Assurance at Cured Pharmacy

At Cured Pharmacy, we maintain continuous stock of all Mounjaro dose strengths and offer our price match assurance to ensure you receive the most competitive pricing available from UK-registered pharmacies. Our transparent pricing structure means you'll see the exact cost before completing your clinical assessment, with no hidden consultation fees or surprise charges.

We stock Mounjaro at £124.99 for the starter dose, with maintenance doses priced competitively based on strength. If you find a lower price from another GPhC-registered UK pharmacy for the same Mounjaro dose, we'll match it. This guarantee applies to like-for-like comparisons with legitimate UK-licensed pharmacies dispensing genuine Eli Lilly Mounjaro pens.

Our superintendent pharmacist, Tarun Kumar (GPhC 2233073), personally oversees our supply chain to ensure uninterrupted stock availability. Unlike some pharmacies that experience frequent shortages, we maintain robust stock levels across all dose strengths and offer next-day discreet delivery as standard. Your prescription is dispensed from our GPhC-registered premises (registration 9012511) and arrives in unmarked packaging.

Comparing Mounjaro to Other Weight Loss Treatments

When considering prescription weight loss medication, UK patients typically evaluate options including Mounjaro, Wegovy, and Saxenda — all GLP-1 or dual-agonist injectable treatments licensed by the MHRA. Each medication has distinct characteristics that may make it more suitable depending on your clinical profile and treatment goals.

Wegovy contains semaglutide, a single GLP-1 receptor agonist that demonstrated average weight loss of 14.9% over 68 weeks in the STEP-1 trial [5]. Whilst this represents significant efficacy, head-to-head comparisons suggest tirzepatide produces greater weight reduction on average. Saxenda uses liraglutide, an earlier-generation GLP-1 agonist requiring daily injections rather than weekly administration.

For patients who prefer oral medication, we also offer alternatives like Orlistat and Xenical, which work by reducing dietary fat absorption rather than affecting appetite hormones. These treatments suit patients who cannot tolerate injectable medications or prefer a non-systemic approach. Your UK prescriber will discuss all suitable options during your consultation, considering your medical history, weight loss goals, and personal preferences.

Clinical Considerations for Treatment Selection

Your prescriber considers multiple factors when recommending a specific weight loss treatment. Medical history including cardiovascular disease, thyroid conditions, and previous bariatric surgery all influence treatment selection. Mounjaro may be particularly appropriate for patients with type 2 diabetes due to its dual mechanism improving glycaemic control alongside weight reduction [1].

Cost considerations also matter for long-term treatment adherence. Whilst Mounjaro represents a significant investment, the once-weekly injection schedule and superior efficacy in clinical trials may provide better value over time compared to daily injectable alternatives. Our transparent pricing and price match assurance help make treatment more accessible to UK patients seeking effective weight management support.

Mounjaro Side Effects and Safety Considerations

The most common side effects of Mounjaro are gastrointestinal, occurring in approximately 20-40% of patients during dose escalation [4]. These include nausea, diarrhoea, vomiting, constipation, and abdominal discomfort. Most gastrointestinal effects are mild to moderate, occur primarily during the first few weeks after starting or increasing doses, and typically resolve without intervention.

More serious but rare adverse effects include pancreatitis, gallbladder disease, and hypoglycaemia (particularly in patients taking other diabetes medications). Mounjaro carries a boxed warning regarding thyroid C-cell tumours observed in rodent studies, though human relevance remains uncertain [4]. The medication is contraindicated in patients with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2.

Before prescribing Mounjaro, your UK clinician will review your complete medical history, current medications, and any contraindications. Patients with severe gastrointestinal disease, previous pancreatitis, or diabetic retinopathy require careful assessment. Mounjaro is not recommended during pregnancy or breastfeeding, and women of childbearing potential should use effective contraception during treatment. All prescription medications dispensed through Cured Pharmacy include comprehensive patient information leaflets detailing side effects and safety precautions.

Starting Your Mounjaro Treatment with Cured Pharmacy

Beginning treatment is straightforward with our streamlined online consultation process. You'll complete a comprehensive medical questionnaire covering your weight history, current health conditions, medications, and weight loss goals. This assessment typically takes under three minutes and is reviewed by a UK-registered prescriber who determines whether Mounjaro is clinically appropriate for you.

If approved, your prescription is sent electronically to our pharmacy team, and we dispense your medication the same day for next-day delivery. Your first prescription typically includes the 2.5mg starter dose along with detailed administration instructions. We provide ongoing support throughout your treatment journey, with easy prescription renewals and access to our clinical team for any questions or concerns.

Our service includes free follow-up consultations when progressing to higher doses. Your prescriber monitors your progress, adjusts dosing as needed, and ensures you're tolerating treatment appropriately. We maintain detailed records of your treatment history, making dose escalations and renewals seamless. All communications are handled discreetly, and our packaging contains no external pharmacy branding or medication descriptions.

Ongoing Support and Monitoring

Successful weight loss with Mounjaro involves more than just medication. We encourage patients to combine treatment with sustainable dietary changes and increased physical activity for optimal results. Your prescriber can provide guidance on evidence-based lifestyle modifications that complement tirzepatide's metabolic effects.

Regular monitoring helps ensure treatment remains safe and effective. We recommend tracking your weight monthly and reporting any concerning side effects promptly. Most patients remain on Mounjaro for 12-24 months, with some requiring longer treatment depending on individual circumstances. Your prescriber will discuss appropriate treatment duration during your consultations, considering factors like weight loss achieved, side effects experienced, and long-term maintenance strategies.

Scientific References

1. Ludvik, B., et al. (2021). Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial. The Lancet, 398(10300), 583-598. https://doi.org/10.1016/S0140-6736(21)01443-4 [accessed 13 August 2026]
2. Jastreboff, A. M., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205-216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
3. Frias, J. P., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503-515. https://doi.org/10.1056/NEJMoa2107519 [accessed 13 August 2026]
4. Eli Lilly and Company. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen - Summary of Product Characteristics. Medicines and Healthcare products Regulatory Agency. https://www.medicines.org.uk/emc/product/14298 [accessed 13 August 2026]
5. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989-1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
6. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
7. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
8. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and weight loss outcomes depend on multiple factors including adherence to treatment, lifestyle modifications, and individual metabolic response.